Reactive Oxygen Species in Cardiometabolic Syndrome, Neuronal Diseases and Cancer
From Bench to its Potential Therapeutics
- 1st Edition - August 1, 2025
- Latest edition
- Editors: Esma R. Isenović, Jasjit S. Suri
- Language: English
Reactive Oxygen Species in Cardiometabolic Syndrome, Neuronal Diseases and Cancer: From Bench to its Potential Therapeutics systematically summarizes findings concerning the bioche… Read more
World Book Day celebration
Where learning shapes lives
Up to 25% off trusted resources that support research, study, and discovery.
Description
Description
This is a must-have reference for scientists and medical professionals seeking to enhance their knowledge of ROS research and the impact on treatments for cardiometabolic syndrome, neuronal diseases, and cancer.
Key features
Key features
- Provides a foundation on reactive oxygen species (ROS), ROS signaling, and regulation of gene expression
- Presents an overview of the molecular mechanisms of ROS in reactive oxygen species in cardiometabolic syndrome, specific neural diseases, and cancer
- Reviews recent findings on ROS and regulation of gene expression
- Covers the effects of antioxidant supplementation
Readership
Readership
Table of contents
Table of contents
1. ROS in general
2. ROS signaling
3. ROS and regulation of gene expression
Section 2. ROS in cardiometabolic syndrome
4. Molecular Mechanisms of ROS in cardiometabolic syndrome
5. Molecular Mechanisms of ROS and Regulation of Gene expression in cardiometabolic syndrome
6. Antioxidant supplementation and Cardiometabolic syndrome
Section 3. ROS and neuronal diseases
7. Molecular Mechanisms of ROS in neurodegenerative diseases (Alzheimer, Parkinson, etc.)
8. ROS and psychiatric diseases (schizophrenia, etc.)
9. Antioxidant supplementation and neuronal diseases
Section 4. ROS and cancer
10. ROS and early stage of cancer (cancer development)
11. ROS and late-stage cancer (cancer metastasis)
12. Antioxidant supplementation and cancer
Section 5. Summary and concluding remarks
Product details
Product details
- Edition: 1
- Latest edition
- Published: August 27, 2025
- Language: English
About the editors
About the editors
EI
Esma R. Isenović
Esma R. Isenovic, PhD is a full professor/principal research fellow and Head of the Laboratory for Endocrinology, Hypertension, and Metabolic Diseases in the Department of Radiobiology and Molecular Genetics at the "VINA" Institute of Nuclear Sciences - National Institute of The Republic of Serbia, University of Belgrade, Serbia. Professor Isenovic's research interests over the last 25 years have been diabetes and cardiovascular diseases and the effects of various hormones on cardiovascular biology. She serves as an invited reviewer for 181 international scientific journals, on the Editorial Boards of 26 international scientific journals, and on the editorial boards of twelve international journals. Professor Isenovic has extensive experience in the international research program and proposal evaluation as an expert reviewer. She has published over 200 scientific papers in peer-reviewed journals and 24 book chapters.
JS
Jasjit S. Suri
Dr. Jasjit Suri, PhD, MBA, is a renowned innovator and scientist. He received the Director General’s Gold Medal in 1980 and is a Fellow of several prestigious organizations, including the American Institute of Medical and Biological Engineering and the Institute of Electrical and Electronics Engineers. Dr. Suri has been honored with lifetime achievement awards from Marcus, NJ, USA, and Graphics Era University, India. He has published nearly 300 peer-reviewed AI articles, 100 books, and holds 100 innovations/trademarks, achieving an H-index of nearly 100 with about 43,000 citations. Dr. Suri has served as chairman of AtheroPoint, IEEE Denver section, and as an advisory board member to various healthcare industries and universities globally.